Physician profile
Hung S Ho
NPI 1417930785
$25,047.15
in general payments reported to CMS, 2019-2025
14 companies · $7,455 in 2025
The $7,455 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,709 · 2020: $170 · 2021: $564 · 2022: $2,647 · 2023: $4,541 · 2024: $5,961 · 2025: $7,455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $11K · Food and Beverage: $4,443 · Education: $2,910.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,604.00 |
| Food and Beverage | $4,442.89 |
| Education | $2,910.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $8,929.06 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Intuitive Surgical, INC. | $7,918.53 | 2019-2025 | Da Vinci Surgical System |
| Davol INC. | $3,990.36 | 2019-2025 | Phasix Mesh |
| Becton, Dickinson and Company | $1,543.98 | 2023-2024 | Phasix Mesh |
| Kci USA, INC. | $874.55 | 2019 | |
| Conmed Corporation | $540.06 | 2021-2025 | Airseal |
| Integra Lifesciences Corporation | $383.83 | 2022 | |
| Tei Biosciences INC | $375.08 | 2019 | |
| Octapharma USA, INC. | $126.49 | 2025 | Fibryga |
| Endogastric Solutions, INC | $117.72 | 2023 | Esophyx |
| Baudax Bio INC. | $76.98 | 2021 | |
| Medical Device Business Services, INC. | $76.11 | 2019 | |
| Teleflex LLC | $48.95 | 2024 | Titan Sgs |
| Nobel Biocare USA | $45.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hung Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.